Browsing by Author Tsoi, H

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 16 of 16
TitleAuthor(s)Issue Date
 
A Novel Splice Variant to NCOR2 as Biomarker for Tamoxifen Resistant Breast Cancer
Proceeding/Conference:WIN 2017 Symposium
Ellis, IMan, PSLee, TKWTsoi, HWong, LSLuk, MYRakha, EALam, EWFGreen, ARCheung, KLCheung, KLKhoo, US
2017
 
Androgen Receptor as an Emerging Feasible Biomarker for Breast Cancer
Journal:Biomolecules
You, CLeung, MHTSANG, WCKhoo, USTsoi, H
2022
 
Checkpoint Kinase 2 Inhibition Can Reverse Tamoxifen Resistance in ER-Positive Breast Cancer
Journal:International Journal of Molecular Sciences
Tsoi, HTSANG, WCMan, PSLeung, MHYou, CChan, SYChan, WLWKhoo, US
2022
 
Combined use of Ivabradine and Olaparib as a novel therapeutic strategy for triple-negative breast cancer
Proceeding/Conference:The Virtual New Zealand Breast Cancer Symposium, 2021
Leung, MHTsoi, HMan, PSGong, CKhoo, US
2021
 
Hyperpolarization-activated cyclic nucleotide-gated channel (HCN) blocker, Ivabradine, a novel potential targeted treatment for triple-negative breast cancer.
Proceeding/Conference:European Journal of Cancer
Khoo, USMok, KCTsoi, HMan, PSChau, KMLee, TKGong, C
2018
 
KPNA1 mediates the nuclear import of BQ323636.1 and confer tamoxifen resistance in breast cancer cells
Proceeding/Conference:Cancer Research
Mok, KCTsoi, HChou, KMKhoo, USMan, PS
2018
 
KPNA1 regulates nuclear import of NCOR2 splice variant BQ323636.1 to confer tamoxifen resistance in breast cancer
Journal:Clinical and Translational Medicine
Tsoi, HMan, PSLeung, MHMOK, KCChau, KMWong, LSChan, WLWChan, SYLuk, MYCheng, CNKhoo, US
2021
 
Modulating the Activity of Androgen Receptor for Treating Breast Cancer
Journal:International Journal of Molecular Sciences
You, CTsoi, HMan, PSLeung, MHKhoo, US
2022
 
Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer
Journal:Life
Tsoi, HSHI, LLeung, MHMan, PSSo, ZQChan, WLWKhoo, US
2022
 
Overexpression of BQ323636.1 modulates tamoxifen resistance in ER positive breast cancer via IL-8-mediated signaling pathway
Proceeding/Conference:Cancer Research
Shi, LSTsoi, HDong, MMan, EPSKhoo, US
2019
 
Repurposing hyperpolarization‐activated cyclic nucleotide‐gated channels as a novel therapy for breast cancer
Journal:Clinical and Translational Medicine
MOK, KCTsoi, HMan, PSLeung, MHChau, KMWong, LSChan, WLWChan, SYLuk, MYChan, YWLeung, KMChan, HYSilva Coimbra Batalha, SLLau, VYMSiu, DCWLee, KWGong, CKhoo, US
2021
 
Targeting androgen receptor in BQ323636.1 overexpressing ER+ breast cancer to overcome aromatase inhibitor resistance
Proceeding/Conference:The Virtual New Zealand Breast Cancer Symposium, 2021
Lok, JTsoi, HMan, PSChan, WLWChan, SYCheng, CNKhoo, US
2021
 
Targeting CHK2 to reverse tamoxifen resistance by reducing BQ323636.1 in ER-positive breast cancer
Proceeding/Conference:The Virtual New Zealand Breast Cancer Symposium, 2021
Tsoi, HMan, PSTSANG, WCWong, LSChan, WLWChan, SYKhoo, US
2021
 
Targeting Ribosome Biogenesis to Combat Tamoxifen Resistance in ER+ve Breast Cancer
Journal:Cancers
Tsoi, HYOU, CLeung, MHMan, PSKhoo, US
2022
 
The NCOR2 Splice Variant as Genomic Biomarker for Breast Cancer
Proceeding/Conference:BIT's 17th Annual Congress of International Drug Discovery Science and Technology-2019 (IDDST-2019)
Khoo, USGong, CLeung, MHTsoi, H
2019
 
The role of BQ323636.1, a novel splice variant of NCOR2, in modulation of oxidative stress in breast cancer
Proceeding/Conference:AACR Advances in Breast Cancer Research Special Conference, Hollywood, California
Leung, MHTsoi, HMan, EPSLam, EWFKhoo, US
2017
Showing results 1 to 16 of 16